GlycoMimetics, Inc.
HIGHLY POTENT MULTIMERIC E-SELECTIN ANTAGONISTS
Last updated:
Abstract:
Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of an E-selectin to an E-selectin ligand are disclosed. For example, highly potent multimeric E-selectin antagonist are dessorbed and pharmaceutical compositions comprising at least one of the same.
Status:
Application
Type:
Utility
Filling date:
15 Jun 2021
Issue date:
21 Oct 2021